메뉴 건너뛰기




Volumn 40, Issue 5, 2012, Pages 381-388

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance

Author keywords

Abnormal behaviour; Laninamivir; Post marketing surveillance; Safety

Indexed keywords

LANINAMIVIR OCTANOATE;

EID: 84867403055     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.06.017     Document Type: Short Survey
Times cited : (30)

References (29)
  • 3
    • 48249093320 scopus 로고    scopus 로고
    • World Health Organization Geneva, Switzerland: WHO. [accessed 03.07.12]
    • World Health Organization. Influenza A(H1N1) virus resistance to oseltamivir. Geneva, Switzerland: WHO. http://www.who.int/influenza/patient- care/antivirals/oseltamivir-summary/en/. [accessed 03.07.12].
    • Influenza A(H1N1) Virus Resistance to Oseltamivir
  • 4
    • 84875004426 scopus 로고    scopus 로고
    • US Centers for Disease Control and Prevention Atlanta, GA: CDC. [accessed 03.07.12]
    • US Centers for Disease Control and Prevention. 2008-2009 Influenza season week 17 ending May 2, 2009. Atlanta, GA: CDC. http://www.cdc.gov/h1n1flu/pubs/ pdf/FluView-Week17.pdf. [accessed 03.07.12].
    • (2009) 2008-2009 Influenza Season Week 17 Ending May 2
  • 7
    • 71149117904 scopus 로고    scopus 로고
    • World Health Organization Geneva, Switzerland: WHO. [accessed 02.07.12]
    • World Health Organization. Pandemic (H1N1) 2009 - update 105. Geneva, Switzerland: WHO. http://www.who.int/csr/don/2010-06-18/en/index.html. [accessed 02.07.12].
    • Pandemic (H1N1) 2009 - Update 105
  • 9
  • 10
    • 4444369826 scopus 로고    scopus 로고
    • Resistant influenza A viruses in children treated with oseltamivir: Descriptive study
    • M. Kiso, K. Mitamura, Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, and K. Kimura Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 2004 759 765
    • (2004) Lancet , vol.364 , pp. 759-765
    • Kiso, M.1    Mitamura, K.2    Sakai-Tagawa, Y.3    Shiraishi, K.4    Kawakami, C.5    Kimura, K.6
  • 11
    • 34047226373 scopus 로고    scopus 로고
    • Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
    • S. Hatakeyama, N. Sugaya, M. Ito, M. Yamazaki, M. Ichikawa, and K. Kimura Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors JAMA 297 2007 1435 1442
    • (2007) JAMA , vol.297 , pp. 1435-1442
    • Hatakeyama, S.1    Sugaya, N.2    Ito, M.3    Yamazaki, M.4    Ichikawa, M.5    Kimura, K.6
  • 12
    • 59749091876 scopus 로고    scopus 로고
    • CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity
    • M. Yamashita, T. Tomozawa, M. Kakuta, A. Tokumitsu, H. Nasu, and S. Kubo CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity Antimicrob Agents Chemother 53 2009 186 192
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 186-192
    • Yamashita, M.1    Tomozawa, T.2    Kakuta, M.3    Tokumitsu, A.4    Nasu, H.5    Kubo, S.6
  • 13
    • 77149156604 scopus 로고    scopus 로고
    • Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration
    • S. Kubo, T. Tomozawa, M. Kakuta, M. Kakuta, A. Tokumitsu, and M. Yanashita Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration Antimicrob Agents Chemother 54 2010 1256 1264
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 1256-1264
    • Kubo, S.1    Tomozawa, T.2    Kakuta, M.3    Kakuta, M.4    Tokumitsu, A.5    Yanashita, M.6
  • 14
    • 69149093400 scopus 로고    scopus 로고
    • In vitro and in vivo characterization of new swine-origin H1N1 influenza virus
    • Y. Itoh, K. Shinya, M. Kiso, T. Watanabe, Y. Sakoda, and M. Hatta In vitro and in vivo characterization of new swine-origin H1N1 influenza virus Nature 460 2009 1021 1025
    • (2009) Nature , vol.460 , pp. 1021-1025
    • Itoh, Y.1    Shinya, K.2    Kiso, M.3    Watanabe, T.4    Sakoda, Y.5    Hatta, M.6
  • 15
    • 77649254587 scopus 로고    scopus 로고
    • Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses
    • M. Kiso, S. Kubo, M. Ozark, Q. Male Le, C.A. Nimrod, and M. Yamashita Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses PLoS Pathog 6 2010 e1000786
    • (2010) PLoS Pathog , vol.6 , pp. 1000786
    • Kiso, M.1    Kubo, S.2    Ozark, M.3    Male Le, Q.4    Nimrod, C.A.5    Yamashita, M.6
  • 16
    • 77952611625 scopus 로고    scopus 로고
    • Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection
    • N. Sugaya, and Y. Hashish Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection Antimicrob Agents Chemother 54 2010 2575 2582
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2575-2582
    • Sugaya, N.1    Hashish, Y.2
  • 17
    • 78349241129 scopus 로고    scopus 로고
    • Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial
    • MARVEL Study Group
    • A. Watanabe, S.C. Chang, M.J. Kim, D.W. Chu, Y. Ohashi MARVEL Study Group Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial Clin Infect Dis 51 2010 1167 1175
    • (2010) Clin Infect Dis , vol.51 , pp. 1167-1175
    • Watanabe, A.1    Chang, S.C.2    Kim, M.J.3    Chu, D.W.4    Ohashi, Y.5
  • 18
    • 67349160808 scopus 로고    scopus 로고
    • Epidemiological survey of influenza-associated complications I. Clinical assessment of symptoms and signs, and medication
    • [in Japanese]
    • S. Yokota, T. Fujita, M. Mori, A. Nezu, A. Okumura, and M. Hosoya Epidemiological survey of influenza-associated complications I. Clinical assessment of symptoms and signs, and medication Jap J Pediatric Infect 111 2007 1545 1558 [in Japanese]
    • (2007) Jap J Pediatric Infect , vol.111 , pp. 1545-1558
    • Yokota, S.1    Fujita, T.2    Mori, M.3    Nezu, A.4    Okumura, A.5    Hosoya, M.6
  • 19
    • 70350328007 scopus 로고    scopus 로고
    • CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract
    • K. Koyama, M. Takahashi, M. Oitate, N. Nakai, H. Takakusa, and S. Miura CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract Antimicrob Agents Chemother 53 2009 4845 4851
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 4845-4851
    • Koyama, K.1    Takahashi, M.2    Oitate, M.3    Nakai, N.4    Takakusa, H.5    Miura, S.6
  • 20
    • 80053637254 scopus 로고    scopus 로고
    • Unique characteristics of long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) that explains its long-lasting activity
    • M. Yamashita, T. Hirai, K. Kubota, and S. Kubo Unique characteristics of long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) that explains its long-lasting activity Influenza Other Respir Viruses 5 Suppl. 1 2011 93 95
    • (2011) Influenza Other Respir Viruses , vol.5 , Issue.SUPPL. 1 , pp. 93-95
    • Yamashita, M.1    Hirai, T.2    Kubota, K.3    Kubo, S.4
  • 21
    • 78751692669 scopus 로고    scopus 로고
    • Laninamivir and its prodrug, CS-8958: Long-acting neuraminidase inhibitor for the treatment of influenza
    • M. Yamashita Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitor for the treatment of influenza Antivir Chem Chemother 21 2010 74 84
    • (2010) Antivir Chem Chemother , vol.21 , pp. 74-84
    • Yamashita, M.1
  • 24
    • 56749106483 scopus 로고    scopus 로고
    • Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: A comprehensive review
    • S. Toovey, C. Rayner, E. Prinssen, T. Chi, B. Donner, and B. Thakrar Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review Drug Saf 31 2008 1097 1114
    • (2008) Drug Saf , vol.31 , pp. 1097-1114
    • Toovey, S.1    Rayner, C.2    Prinssen, E.3    Chi, T.4    Donner, B.5    Thakrar, B.6
  • 25
    • 58849093994 scopus 로고    scopus 로고
    • The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand
    • [in Japanese]
    • N. Tomono, and H. Shiro The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand Kansenshogaku Zasshi 82 2008 613 618 [in Japanese]
    • (2008) Kansenshogaku Zasshi , vol.82 , pp. 613-618
    • Tomono, N.1    Shiro, H.2
  • 26
    • 77951648151 scopus 로고    scopus 로고
    • Prospective studies on neurological symptoms associated with influenza virus infection during the 2006-2007 influenza season (part 2) - Abnormal behaviors
    • M. Tominaga, T. Tanabe, K. Hara, C. Kinoshita, T. Kasahara, and M. Kou Prospective studies on neurological symptoms associated with influenza virus infection during the 2006-2007 influenza season (part 2) - abnormal behaviors J Pediatr Infect Dis Immunol 19 2007 468 472
    • (2007) J Pediatr Infect Dis Immunol , vol.19 , pp. 468-472
    • Tominaga, M.1    Tanabe, T.2    Hara, K.3    Kinoshita, C.4    Kasahara, T.5    Kou, M.6
  • 27
    • 70449636163 scopus 로고    scopus 로고
    • Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
    • S. Jain, L. Kamimoto, A.M. Bramley, A.M. Schmitz, S.R. Benoit, and J. Louie Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 N Engl J Med 361 2009 1935 1944
    • (2009) N Engl J Med , vol.361 , pp. 1935-1944
    • Jain, S.1    Kamimoto, L.2    Bramley, A.M.3    Schmitz, A.M.4    Benoit, S.R.5    Louie, J.6
  • 28
    • 77951625950 scopus 로고    scopus 로고
    • Epidemiological survey of influenza-associated complications II. A statistical analysis of symptoms and signs, and medication
    • T. Fujita, M. Mori, A. Nezu, A. Okumura, M. Hosoya, and H. Suzuki Epidemiological survey of influenza-associated complications II. A statistical analysis of symptoms and signs, and medication Jap J Pediatr Infect 111 2007 1559 1567
    • (2007) Jap J Pediatr Infect , vol.111 , pp. 1559-1567
    • Fujita, T.1    Mori, M.2    Nezu, A.3    Okumura, A.4    Hosoya, M.5    Suzuki, H.6
  • 29
    • 79955660384 scopus 로고    scopus 로고
    • A pharmacoepidemiological study on the relationship between neuropsychiatric symptoms and therapeutic drugs after influenza infection
    • T. Fujita, Y. Fujii, Y. Watanabe, H. Osaka, T. Wada, and M. Mori A pharmacoepidemiological study on the relationship between neuropsychiatric symptoms and therapeutic drugs after influenza infection Jpn J Pharmacoepidemiol 15 2010 73 95
    • (2010) Jpn J Pharmacoepidemiol , vol.15 , pp. 73-95
    • Fujita, T.1    Fujii, Y.2    Watanabe, Y.3    Osaka, H.4    Wada, T.5    Mori, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.